Orchestra BioMed (OBIO) vs Trulieve Cannabis Subordinate Voting Shares (TRLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Orchestra BioMed (OBIO) has outperformed Trulieve Cannabis Subordinate Voting Shares (TRLV) over the past year, gaining 107.3% versus a gain of 21.3%. Over five years, OBIO leads with a -42.5% price change compared with -58.9% for TRLV. Trulieve Cannabis Subordinate Voting Shares is the larger company by market cap ($2.00 billion vs $344.4 million), about 5.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OBIO | TRLV |
|---|---|---|
| Share price | $5.73 | $10.37 |
| Market cap | $344.40M | $2.00B |
| 1-day change | +1.24% | -3.80% |
| YTD return | +36.39% | +24.05% |
| 1-year return | +107.33% | +21.26% |
| 5-year return | -42.54% | -58.89% |
| Forward P/E | — | 18.63 |
| EPS (TTM) | $-0.86 | $-2.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.50 | $13.28 |
| 52-week low | $2.78 | $4.62 |
| Distance from 52-week high | -11.85% | -21.91% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +116.93% | +75.31% |
| Average volume | 299.24K | 1.60M |
| Shares outstanding | 60.11M | 170.16M |
| Employees | 86 | 5,000 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Trulieve Cannabis Subordinate Voting Shares is about 5.8 times larger than Orchestra BioMed by market value ($2.00B vs $344.40M).
- OBIO has outperformed TRLV by 86.1 percentage points over the past year.
- The two companies sit in different sectors: Orchestra BioMed in Healthcare and Trulieve Cannabis Subordinate Voting Shares in Health Care.
About Orchestra BioMed
OBIO stock →Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Healthcare · Biotechnology · 86 employees
About Trulieve Cannabis Subordinate Voting Shares
TRLV stock →Trulieve Cannabis Corp. operates as a cannabis retailer in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 5,000 employees
OBIO vs TRLV FAQ
Which is bigger, Orchestra BioMed or Trulieve Cannabis Subordinate Voting Shares?
Trulieve Cannabis Subordinate Voting Shares (TRLV) is larger, with a market capitalization of $2.00B compared with $344.40M for Orchestra BioMed (OBIO).
Which stock has performed better over the past year, OBIO or TRLV?
OBIO returned +107.33% over the past 12 months, compared with +21.26% for TRLV (price return, excluding dividends). Past performance does not predict future results.
Are Orchestra BioMed and Trulieve Cannabis Subordinate Voting Shares in the same industry?
No. Orchestra BioMed is in the Healthcare sector, while Trulieve Cannabis Subordinate Voting Shares is in Health Care.